Search

Author/Creator Collins, Graham P.

1. A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience. (29th April 2022)

Authors:
Kuhnl, Andrea; Roddie, Claire; Kirkwood, Amy A.; Tholouli, Eleni; Menne, Tobias; Patel, Amit; Besley, Caroline; Chaganti, Sridhar; Sanderson, Robin; O'Reilly, Maeve; Norman, Jane; Osborne, Wendy; Bloor, Adrian; Lugthart, Sanne; Malladi, Ram; Patten, Piers E. M.; Neill, Lorna; Martinez‐Cibrian, Nu...
Journal:
British journal of haematology
Issue:
Volume 198:Number 3(2022)
Page Start:
492
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer. Issue 1 (17th October 2018)

Authors:
Eyre, Toby A.; Collins, Graham P.; Gupta, Avinash; Coupe, Nicholas; Sheikh, Semira; Whittaker, John; Wang, Lai Mun; Campo, Leticia; Soilleux, Elizabeth; Tysoe, Finn; Cousins, Richard; La Thangue, Nick; Folkes, Lisa K.; Stratford, Michael R. L.; Kerr, David; Middleton, Mark R.
Journal:
Cancer
Issue:
Volume 125:Issue 1(2019)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies. Issue 11 (19th September 2021)

Authors:
Collins, Graham P.; Clevenger, Tracy N.; Burke, Kathleen A.; Yang, Buyue; MacDonald, Alex; Cunningham, David; Fox, Christopher P.; Goy, Andre; Gribben, John; Nowakowski, Grzegorz S.; Roschewski, Mark; Vose, Julie M.; Vallurupalli, Anusha; Cheung, Jean; Raymond, Amelia; Nuttall, Barrett; Stetson, ...
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 11(2021)
Page Start:
2625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021)

Authors:
Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A.; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel...
Journal:
HemaSphere
Issue:
Volume 5:Issue 11(2021)
Page Start:
e656
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL. Issue 4 (9th September 2019)

Authors:
Eyre, Toby A.; Hildyard, Catherine; Hamblin, Angela; Ali, Ayesha S.; Houlton, Aimee; Hopkins, Louise; Royston, Daniel; Linton, Kim M.; Pettitt, Andrew; Rule, Simon; Cwynarski, Kate; Barrington, Sally F.; Warbey, Victoria; Wrench, David; Barrans, Sharon; Hirst, Caroline S.; Panchal, Anesh; Roudier...
Journal:
Hematological oncology
Issue:
Volume 37:Issue 4(2019)
Page Start:
352
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Burkitt Lymphoma International Prognostic Index. Issue 10 (1st April 2021)

Authors:
Olszewski, Adam J.; Jakobsen, Lasse H.; Collins, Graham P.; Cwynarski, Kate; Bachanova, Veronika; Blum, Kristie A.; Boughan, Kirsten M.; Bower, Mark; Dalla Pria, Alessia; Danilov, Alexey; David, Kevin A.; Diefenbach, Catherine; Ellin, Fredrik; Epperla, Narendranath; Farooq, Umar; Feldman, Tatyana...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 10(2021)
Page Start:
1129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗